Eyenovia, Inc. engages in developing therapeutics based on its proprietary microdose array print platform technology.The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. Its product candidates include MicroLine, MicroPine and MydCombi.
